ReviewFrontiers in pharmacology2018

Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis.

Anita Balázs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.